V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007903 | 250005478 | 1.8 | 79.5 | null | 2018-08-21 | 2018-08-21 | Trial Unspecified | 2 | N | 250004215 | PEMETREXED |
| 250007904 | 250005479 | 1.62 | null | null | 2018-11-18 | 2018-11-20 | Cytarabine Low Dose | 02 | N | 250004229 | TRIAL |
| 250007905 | 250005479 | 0 | 51.6 | Curative (C) | 2013-03-26 | 2013-03-26 | Trial Unspecified | 02 | N | 250004229 | TRIAL |
| 250007906 | 250005480 | 1.61 | null | Disease modification (D) | 2016-11-28 | 2016-12-04 | BCG Intravesical | N | N | 250004352 | TRIAL |
| 250007907 | 250005480 | 1.55 | 0 | Disease modification (D) | 2017-09-01 | 2017-09-01 | CARBOPLATIN + ETOPOSIDE | N | N | 250004352 | VINORELBINE |
| 250007908 | 250005481 | 1.6 | 49.5 | null | 2016-07-29 | 2016-08-15 | Trial Unspecified | N | N | 250004433 | IPM |
| 250007909 | 250005482 | null | 91.6 | Disease modification (D) | 2019-07-06 | 2019-07-21 | Pemetrexed | N | null | 250004492 | TRIAL |
| 250007910 | 250005483 | 0 | 0 | Neo-adjuvant (N) | 2017-12-30 | 2018-01-24 | Cisplatin + Docetaxel | 02 | N | 250004667 | TRIAL |
| 250007911 | 250005484 | 1.66 | 76 | Disease modification (D) | 2015-12-05 | 2016-01-08 | Trial Unspecified | N | N | 250004688 | CVP R |
| 250007912 | 250005485 | 1.64 | 43.6 | Disease modification (D) | 2019-02-06 | 2019-02-06 | Vinorelbine (oral) | 02 | N | 250004732 | CISPLATIN + PACLITAXEL |
| 250007913 | 250005485 | -1 | 78.6 | Palliative (P) | 2017-09-10 | 2017-10-29 | Cytarabine Low Dose | N | N | 250004732 | CARBOPLATIN + ETOPOSIDE |
| 250007914 | 250005486 | 1.67 | null | Palliative (P) | 2018-01-18 | 2018-01-18 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 250004827 | TRIAL |
| 250007915 | 250009868 | null | null | Not known (9) | null | 2016-12-17 | Carboplatin AUC 6 - 10 | null | N | 250004853 | TRIAL |
| 250007916 | 250005487 | null | 73 | Palliative (P) | 2019-03-09 | 2019-03-09 | PEMBROLIZUMAB | Y | N | 250004861 | FEC |
| 250007917 | 250005487 | 1.61 | null | Palliative (P) | 2013-09-16 | 2013-09-16 | COMMAND trial | N | N | 250004861 | TRIAL |
| 250007918 | 250005488 | 1.5 | 74.4 | Disease modification (D) | 2017-07-16 | 2017-07-21 | CARBOPLATIN + PACLITAXEL | 2 | N | 250005040 | CISPLATIN + PACLITAXEL |
| 250007919 | 250005488 | 1.7 | 81.8 | Palliative (P) | 2015-10-06 | 2015-10-06 | IPM | 2 | N | 250005040 | VINORELBINE |
| 250007920 | 250011660 | 0 | null | Adjuvant (A) | 2015-05-28 | 2015-05-28 | IPM | 1 | N | 250005104 | CISPLATIN + PACLITAXEL |
| 250007921 | 250011660 | 0 | 0 | Palliative (P) | 2014-11-11 | 2014-11-24 | Pazopanib | N | N | 250005104 | NOT MATCHED |
| 250007922 | 250011660 | 0 | 66.4 | Disease modification (D) | 2018-09-25 | 2018-09-25 | Trial Unspecified | 2 | N | 250005104 | MELPHALAN |
| 250007923 | 250011660 | 1.68 | null | Curative (C) | 2014-05-17 | 2014-05-17 | Not Chemo + Hydroxocobalamin | 1 | N | 250005104 | CARBOPLATIN + ETOPOSIDE |
| 250007924 | 250005489 | null | 63 | Adjuvant (A) | 2017-12-19 | 2018-01-11 | Pemetrexed | null | N | 250005192 | PEMETREXED |
| 250007925 | 250005489 | 1.89 | 79 | Disease modification (D) | 2016-11-10 | 2016-11-11 | EV + LOMUSTINE | 01 | N | 250005192 | IPM |
| 250007926 | 250005489 | 1.76 | 83.6 | Disease modification (D) | 2017-10-31 | 2017-11-01 | GEMCARBO | N | N | 250005192 | VINORELBINE |
| 250007927 | 250005490 | 1.74 | 69 | Palliative (P) | 2016-03-08 | 2016-03-08 | IPM | N | N | 250005535 | TRIAL |
| 250007928 | 250005490 | 0 | 56.5 | Disease modification (D) | 2015-11-16 | 2016-01-16 | Vinorelbine (oral) | 02 | N | 250005535 | NOT MATCHED |
| 250007929 | 250005491 | null | 69 | Adjuvant (A) | 2013-02-04 | 2013-02-06 | Cisplatin + Vinorelbine (PO) | N | Y | 250005543 | IPM |
| 250007930 | 250005491 | 1.83 | 70 | Disease modification (D) | 2016-04-26 | 2016-04-28 | CARBOPLATIN | N | N | 250005543 | VINORELBINE |
| 250007931 | 250005492 | 1.72 | null | null | 2017-12-13 | 2017-12-13 | Carboplatin + Docetaxel | 02 | N | 250005596 | TRIAL |
| 250007932 | 250009874 | null | 67.6 | Curative (C) | 2013-08-25 | 2013-08-25 | Pemetrexed | 01 | N | 250005623 | TRIAL |
| 250007933 | 250009874 | 1.73 | 72 | Disease modification (D) | 2015-06-22 | 2015-07-03 | Trial Unspecified | N | N | 250005623 | TRIAL |
| 250007934 | 250009874 | 1.5 | 58.2 | Palliative (P) | 2017-10-28 | 2017-10-28 | GemCarbo Days 1+8 | 2 | N | 250005623 | TRIAL |
| 250007935 | 250009874 | 1.77 | 80.8 | Palliative (P) | 2016-12-18 | 2016-12-18 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 250005623 | HCX |
| 250007936 | 250009874 | 1.75 | 68 | Disease modification (D) | 2016-10-21 | 2016-11-09 | RUXOLITINIB | N | N | 250005623 | TRIAL |
| 250007937 | 250009874 | 1.61 | 65.5 | Palliative (P) | 2018-05-31 | 2018-06-06 | Pemetrexed | 02 | N | 250005623 | CARBOPLATIN |
| 250007938 | 250005493 | 1.64 | 66.4 | Palliative (P) | 2018-05-24 | 2018-05-24 | Enzalutamide | 2 | N | 250005935 | CARBO + GEFITINIB + PEMETREXED |
| 250007939 | 250005493 | null | null | Palliative (P) | 2017-08-31 | 2017-08-31 | IPM | N | N | 250005935 | GEMCARBO |
| 250007940 | 250005494 | 1.63 | 0 | Curative (C) | 2014-09-21 | 2014-09-27 | EV + LOMUSTINE | N | N | 250006138 | GEMCARBO |
| 250007941 | 250005495 | 0 | null | Disease modification (D) | 2018-02-06 | 2018-02-21 | AML 19 TRIAL | N | N | 250006140 | AML19 TRIAL |
| 250007942 | 250005496 | 1.59 | 54 | Adjuvant (A) | null | 2014-05-11 | Azacitidine | null | null | 250006185 | GEFITINIB |
| 250007943 | 250005497 | 1.7 | 95.7 | Palliative (P) | 2017-03-28 | 2017-03-28 | DA 3 + 10 | 2 | N | 250006244 | GEMCARBO |
| 250007944 | 250005498 | 1.75 | null | Curative (C) | 2016-01-30 | 2016-01-30 | Trial Unspecified | 2 | N | 250006281 | PEMETREXED |
| 250007945 | 250005498 | 1.6 | 72 | Palliative (P) | 2018-06-30 | 2018-07-11 | Pemetrexed | N | N | 250006281 | PEMETREXED |
| 250007946 | 250005499 | 1.58 | 0 | Palliative (P) | 2016-12-01 | 2016-12-18 | IPM | N | N | 250006424 | DA |
| 250007947 | 250005500 | 1.57 | 73 | Disease modification (D) | 2014-11-24 | 2017-09-06 | GemCarbo Days 1+8 | N | N | 250006428 | PEMETREXED |
| 250007948 | 250009877 | 1.66 | null | Adjuvant (A) | null | 2019-05-13 | Trial Unspecified | null | N | 250006507 | TRIAL |
| 250007949 | 250005501 | 1.9 | 0 | Curative (C) | 2018-06-25 | 2018-06-25 | Trial Unspecified | 02 | N | 250006512 | TRIAL |
| 250007950 | 250005502 | 1.81 | 64.3 | Palliative (P) | 2016-05-09 | 2016-05-22 | CHOP R - 21 days | 2 | N | 250006527 | GEFITINIB |
| 250007951 | 250005502 | null | 0 | Disease modification (D) | 2018-09-15 | 2018-09-15 | CARBOPLATIN | N | N | 250006527 | AZACITIDINE |
| 250007952 | 250005502 | 1.72 | 67.2 | Disease modification (D) | 2016-05-24 | 2016-05-31 | IPM | N | N | 250006527 | VINORELBINE |